Research, Bernini: "Extraordinary work at the National Center for Gene Therapy and RNA Drugs"

The minister visits the laboratories of the Vallisneri Complex of the University of Padua, 'the researchers are developing lines of treatment for oncological pathologies, a work in which we strongly believe'

"The core business of research in the laboratories of the Vallisneri Complex of the University of Padua is represented by gene therapies and RNA technology drugs. Apparently we start from Covid, but we go much further because here they are developing lines of treatment for oncological pathologies. Here researchers are doing extraordinary work in which we believe a lot: they are developing the best treatments to live longer and better". This was said by Anna Maria Bernini, Minister of University and Research, during this morning's visit to the laboratories of the Vallisneri Complex of the University of Padua, where one of the most advanced scientific hubs of the National Center for the Development of Gene Therapy and RNA Drugs is located, a research network funded by the NextGeneration Eu program (Pnrr Mission 4 - Education and Research), composed of 32 universities and research institutes, 13 private companies, over 1,000 scientists, more than 500 new researchers and PhD students, of which approximately 200 are operating at the University of Padua. ( Video )

"The research is funded by the PNRR funds and Professor Rosario Rizzuto, president of the center, has always kept us updated on the technological innovations that are being developed. They are also expanding the number of partners, and they are finding companies that believe and invest in this reality", the minister underlined.